123 related articles for article (PubMed ID: 24630889)
1. MCM2/TOP2A (ProExC) immunohistochemistry as a predictive marker in head and neck mucosal biopsies.
Jenson EG; Baker M; Paydarfar JA; Gosselin BJ; Li Z; Black CC
Pathol Res Pract; 2014 Jun; 210(6):346-50. PubMed ID: 24630889
[TBL] [Abstract][Full Text] [Related]
2. Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
Dixon EP; King LM; Nelson R; Simkins SG; Knapp SL; Brough GH; Lenz KL; Henderson DT; Whitehead CM; Hessling J; Brown CA; Malinowski DP
J Immunol Methods; 2017 Mar; 442():35-41. PubMed ID: 28093271
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
4. Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens.
Sanati S; Huettner P; Ylagan LR
Int J Gynecol Pathol; 2010 Jan; 29(1):79-87. PubMed ID: 19952938
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions.
Boucher J; Anku-Bertholet C; Temmar R; Pelmus M
Hum Pathol; 2009 Jun; 40(6):904-5; author reply 905-6. PubMed ID: 19442790
[No Abstract] [Full Text] [Related]
6. Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia.
Piotti KC; Scognamiglio T; Chiu R; Chen YT
Pathol Res Pract; 2013 Nov; 209(11):721-6. PubMed ID: 24011616
[TBL] [Abstract][Full Text] [Related]
7. Utility of ProExC and IMP3 immunocytochemical staining in atypical glandular cells of undetermined significance in liquid-based cervical cytology.
Lastra RR; Ou JJ; Reilly ME; Lawrence WD; Baloch ZW; Brooks JS; Barroeta JE
Diagn Cytopathol; 2014 May; 42(5):375-9. PubMed ID: 23904388
[TBL] [Abstract][Full Text] [Related]
8. A cocktail of MCM2 and TOP2A, p16INK4a and Ki-67 as biomarkers for the improved diagnosis of cervical intraepithelial lesion.
Yang QC; Zhu Y; Liou HB; Zhang XJ; Shen Y; Ji XH
Pol J Pathol; 2013 Apr; 64(1):21-7. PubMed ID: 23625596
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
Wang WC; Wu TT; Chandan VS; Lohse CM; Zhang L
Hum Pathol; 2011 Oct; 42(10):1430-7. PubMed ID: 21420715
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer.
Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN
Tumori; 2014; 100(1):80-6. PubMed ID: 24675496
[TBL] [Abstract][Full Text] [Related]
11. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
Aximu D; Azad A; Ni R; Colgan T; Nanji S
Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
[TBL] [Abstract][Full Text] [Related]
12. ProExC triage of atypical glandular cells on liquid-based cervical cytology specimens.
Fletcher AH; Barklow TA; Murphy NJ; Culbertson LH; Davis AV; Hunter L
J Low Genit Tract Dis; 2011 Jan; 15(1):6-10. PubMed ID: 21192169
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of p16
Ding L; Song L; Zhao W; Li X; Gao W; Qi Z; Wang J
Exp Ther Med; 2020 Apr; 19(4):2457-2466. PubMed ID: 32256722
[TBL] [Abstract][Full Text] [Related]
14. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
Rubin Grandis J; Tweardy DJ; Melhem MF
Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
[TBL] [Abstract][Full Text] [Related]
15. ProEx C stain analysis in recurrent respiratory papillomatosis.
Bhandarkar ND; Sims HS; David O
Ann Otol Rhinol Laryngol; 2010 Feb; 119(2):99-104. PubMed ID: 20336920
[TBL] [Abstract][Full Text] [Related]
16. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
Xu B; Ghossein R; Lane J; Lin O; Katabi N
Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
[TBL] [Abstract][Full Text] [Related]
17. MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation.
Fortuna D; Boman B; O'Neill R; Palazzo J
Hum Pathol; 2017 May; 63():177-183. PubMed ID: 28302537
[TBL] [Abstract][Full Text] [Related]
18. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
[TBL] [Abstract][Full Text] [Related]
19. From epithelial dysplasia to squamous carcinoma of the head and neck region: evolutive and prognostic histopathological markers.
Silvestri F; Bussani R; Pavletic N; Mannone T; Bosatra A
Acta Otolaryngol Suppl; 1997; 527():49-51. PubMed ID: 9197481
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
